Ignite Creation Date:
2024-05-06 @ 1:27 PM
Last Modification Date:
2024-10-26 @ 1:14 PM
Study NCT ID:
NCT04028869
Status:
COMPLETED
Last Update Posted:
2019-07-23
First Post:
2019-07-20
Brief Title:
Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Therapy of Autoimmune Liver Disease
Sponsor:
Beijing Ditan Hospital
Organization:
Beijing Ditan Hospital
Study Overview
Official Title:
Clinical Observation of Long-term Efficacy and Safety of Glycyrrhizic Acid Preparation in the Treatment of Autoimmune Liver Disease
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was a retrospective clinical observation cohort study All patients with autoimmune liver disease treated with glycyrrhizic acid preparations in the Department of Liver Diseases Department of Liver Diseases Beijing Ditan Hospital Capital Medical University were enrolled Clinical follow-up data including demographics hematuria and liver and kidney were collected Functional electrolyte blood glucose PTA erythrocyte sedimentation rate serum AFP and other clinical biochemical indicators and autoantibodies special proteins and liver imaging liver ultrasound examination The clinical effect of glycyrrhizic acid preparation for the treatment of autoimmune liver disease for 144 weeks and the safety during treatment were analyzed
Detailed Description:
This study was a retrospective clinical observation cohort study All patients with autoimmune liver disease treated with glycyrrhizic acid preparations in the Department of Liver Diseases Department of Liver Diseases Beijing Ditan Hospital Capital Medical University were enrolled Clinical follow-up data including demographics hematuria and liver and kidney were collected Functional electrolyte blood glucose PTA erythrocyte sedimentation rate serum AFP and other clinical biochemical indicators and autoantibodies special proteins and liver imaging liver ultrasound examination The clinical effect of glycyrrhizic acid preparation for the treatment of autoimmune liver disease for 144 weeks and the safety during treatment were analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None